Last updated: September 27, 2024
Sponsor: Uppsala University Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Panic Disorders
Kleptomania
Anxiety Disorders
Treatment
Concentrated exposure and response prevention
Clinical Study ID
NCT06621381
2023-07331-01
Ages 6-12 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
The patient fulfills the diagnostic criteria of obsessive-compulsive disorder
The patient and the legal guardians have said yes to receiving the concentratedexposure with response prevention - treatment
Exclusion
Exclusion Criteria:
- The patient/legal guardians are unable to communicate in Swedish
Study Design
Total Participants: 20
Treatment Group(s): 1
Primary Treatment: Concentrated exposure and response prevention
Phase:
Study Start date:
September 11, 2024
Estimated Completion Date:
December 14, 2029
Connect with a study center
Uppsala University Hospital
Uppsala, Region Uppsala 751 85
SwedenActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.